Pharvaris N.V.PHVSNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank12
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P12
Within normal range
vs 3Y Ago
-3.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -8.51% |
| Q2 2025 | -4.50% |
| Q1 2025 | -23.43% |
| Q4 2024 | 21.47% |
| Q3 2024 | 7.12% |
| Q2 2024 | 15.46% |
| Q1 2024 | 7.17% |
| Q4 2023 | 19.28% |
| Q3 2023 | -8.67% |
| Q2 2023 | 7.60% |
| Q1 2023 | 2.37% |
| Q4 2022 | -8.36% |
| Q3 2022 | 2.47% |
| Q2 2022 | 38.36% |
| Q1 2022 | 5.89% |
| Q4 2021 | 26.63% |
| Q3 2021 | -6.23% |
| Q2 2021 | 23.68% |
| Q2 2021 | 83.87% |
| Q4 2020 | 69.42% |
| Q3 2020 | -13.14% |
| Q2 2020 | 65.43% |
| Q1 2020 | -16.86% |
| Q4 2019 | 74.29% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 248.10% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |